在子宫内膜癌中,verteporfin通过PINK1/parkin通路抑制了线粒
Ming-Ming Zhao1, Bo Wang1, Wen-Xi Huang2
1Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University Shanghai 200011, China.
American journal of cancer research
|May 10, 2024
概括
维特波芬通过破坏线粒体和增加反应性氧物种 (ROS) 来抑制子宫内膜癌 (EC) 细胞活力,从而抑制线粒体. 这表明甲状腺素是潜在的EC治疗剂.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 线粒体研究 线粒体研究
背景情况:
- 子宫内膜癌 (EC) 是一个重要的全球妇女健康问题.
- 了解EC细胞生物学对于开发有效治疗方法至关重要.
- 准细胞过程,如线粒细胞衰变,提供了潜在的治疗策略.
研究的目的:
- 为了研究白素对子宫内膜癌 (EC) 细胞的抑制作用.
- 探索背后背脊胺作用的机制,特别是它对线粒体和线粒体细胞的影响.
- 评估脊素作为EC治疗选择的潜力.
主要方法:
- 治疗EC细胞的脊椎细胞.
- 评估线粒体膜潜力和反应性氧物种 (ROS) 水平.
- 细胞增殖,迁移和细胞亡的分析.
- 评估与髓相关的蛋白质表达 (PINK1/帕金,TOM20).
- 使用ROS抑制剂 (N-乙囊) 的救援实验.
主要成果:
- 维特波芬损害了EC细胞的线粒体,降低了膜潜力,增加了ROS.
- 维特波芬抑制了EC细胞的增殖和迁移,同时促进了细胞亡.
- 维特波芬降低了pink1/parkin和tOM20.20等线粒代谢蛋白的表达.
- N-乙半氨酸逆转了脊氨酸对PINK1/parkin表达的影响,表明ROS调解.
结论:
- 维特波芬抑制了EC细胞的活力,可能是通过增加ROS水平和抑制线粒细胞衰变.
- 观察到的效应表明,甲可能成为治疗子宫内膜癌的新疗法.
- 为了EC治疗的开发,需要进一步研究甲的抗菌菌作用.
更多相关视频
09:29Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
7.2K
06:57Author Spotlight: Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells
Published on: May 12, 2023
7.6K
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K